AU2002229452A1 - Method of treating neurological disorders using acetone derivatives - Google Patents

Method of treating neurological disorders using acetone derivatives

Info

Publication number
AU2002229452A1
AU2002229452A1 AU2002229452A AU2002229452A AU2002229452A1 AU 2002229452 A1 AU2002229452 A1 AU 2002229452A1 AU 2002229452 A AU2002229452 A AU 2002229452A AU 2002229452 A AU2002229452 A AU 2002229452A AU 2002229452 A1 AU2002229452 A1 AU 2002229452A1
Authority
AU
Australia
Prior art keywords
neurological disorders
treating neurological
acetone derivatives
acetone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229452A
Inventor
W. Mcintyre Burnham
Serguei S. Likhodi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002229452A1 publication Critical patent/AU2002229452A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
AU2002229452A 2001-02-07 2002-02-07 Method of treating neurological disorders using acetone derivatives Abandoned AU2002229452A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26688301P 2001-02-07 2001-02-07
US60/266,883 2001-02-07
PCT/CA2002/000145 WO2002062327A2 (en) 2001-02-07 2002-02-07 Method of treating neurological disorders using acetone derivatives

Publications (1)

Publication Number Publication Date
AU2002229452A1 true AU2002229452A1 (en) 2002-08-19

Family

ID=23016373

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229452A Abandoned AU2002229452A1 (en) 2001-02-07 2002-02-07 Method of treating neurological disorders using acetone derivatives

Country Status (4)

Country Link
US (2) US20040097598A1 (en)
AU (1) AU2002229452A1 (en)
CA (1) CA2442343A1 (en)
WO (1) WO2002062327A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070567A1 (en) * 2002-08-12 2005-03-31 The Regents Of The University Of Michigan Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
RU2005106855A (en) * 2002-08-12 2005-10-10 Дзе Риджентс оф дзе Юниверсити оф Мичиган (US) DIAGNOSTICS AND TREATMENT OF DISEASES CAUSED BY DEFECTS OF THE CASCADE OF REACTIONS CONDITING TO TUBEROSIS SCLEROSIS
FR2856926B1 (en) * 2003-07-02 2005-09-30 Centre Nat Rech Scient USE OF N-ALKANOLS AS ACTIVATORS OF THE CFTR CHANNEL
FR2861745A1 (en) * 2003-10-31 2005-05-06 Centre Nat Rech Scient Selecting compounds that inhibit the mycobacterial EthR repressor, useful in treatment of tuberculosis and leprosy, improve efficiency of conversion of ethionamide to its active form
GB0410266D0 (en) * 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
US20080207671A1 (en) * 2006-07-31 2008-08-28 The Regents Of The University Of Michigan Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
US20080188461A1 (en) * 2007-02-01 2008-08-07 Regents Of The University Of Michigan Compositions and methods for detecting, preventing and treating seizures and seizure related disorders
US20080268067A1 (en) 2007-03-09 2008-10-30 Llinas Rodolfo R Methods and Compositions for Treating Thalamocortical Dysrhythmia
WO2009102443A2 (en) * 2008-02-15 2009-08-20 The Government Of The Usa, As Represented By The Secretary Of The Dept. Of Health & Human Services; Octanoic acid formulations and methods of treatment using the same
DE102010036179A1 (en) * 2010-09-02 2012-03-08 Beiersdorf Ag Cosmetic preparations with a calming effect
WO2018081118A1 (en) 2016-10-24 2018-05-03 University Of South Florida Delaying latency to seizure by combinations of ketone supplements
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962129A (en) * 1985-12-06 1990-10-09 Elena Avram Treatment of symptoms of neoplastic diseases without treating the diseases themselves
US4997976A (en) * 1988-11-15 1991-03-05 Henri Brunengraber Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5260313A (en) * 1992-03-12 1993-11-09 National Pain Institute, Inc. Diagnosis and treatment of various neuralgias
US6267945B1 (en) * 1998-12-18 2001-07-31 Neuromed Technologies, Inc. Farnesol-related calcium channel blockers
AU1929401A (en) * 1999-12-01 2001-06-12 Alydar Pharmaceuticals Ltd. Method for screening non-peptide, non-steroid inverterbrate pheromones, compositions containing the same and use of the compositions to treat diseases, conditions, and symptoms thereof
US6359015B1 (en) * 2000-02-28 2002-03-19 The United States Of America As Represented By The Department Of Veterans Affairs Method for antagonizing inhibition effects of alcohol on cell adhesion

Also Published As

Publication number Publication date
WO2002062327A2 (en) 2002-08-15
WO2002062327B1 (en) 2003-04-03
WO2002062327A3 (en) 2003-01-16
US20040097598A1 (en) 2004-05-20
US20090042982A1 (en) 2009-02-12
CA2442343A1 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2003297761A1 (en) Methods for treating neurological language disorders
HK1078858A1 (en) Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
AU2003239489A1 (en) Method of treating dyslipidemic disorders
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
IL153425A0 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
AU3977700A (en) Method of treating neurological disorders
IL141263A0 (en) Methods for treatment of neurological disorders
AU2002229452A1 (en) Method of treating neurological disorders using acetone derivatives
AU2001285747A1 (en) Method for the treatment of tobacco
AU1356201A (en) Treatment of hyperproliferative disorders
AU2003270536A1 (en) Method of treating skin disorders
AU4552200A (en) Method of treating psychotic disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU2002229986A1 (en) Method of treating neurological diseases
AU3757300A (en) Method of treating anxiety disorders
AU2003260489A1 (en) Treatment of neurological disorders by dsrna adminitration
AU2001288792A1 (en) Method of treating neurologic disorders
AU2003278084A1 (en) Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders
AUPR381601A0 (en) Method of treating respiratory conditions
AUPR731901A0 (en) Method of treatment
AU2003301346A1 (en) Method of treating neurological diseases and disorders
AU2002237894A1 (en) Methods of treating neurological disorders
AU2003297259A1 (en) Methods and compositions for treating neurological disorders
AU2002229795A1 (en) Method for treating sexual disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase